Published: 11 November 2019
Author(s): G. Sinagra, A. Porcari, M. Merlo
Section: Commentary

Over the last decades, major advances in the understanding of pathophysiology in a wide spectrum of cardiovascular diseases provided several effective pharmacological and non-pharmacological therapies [1]. Along with novel rehabilitation and follow up strategies, these advances have improved the survival rate of cardiac diseases, globally, and contributed generally to a significant increase in life expectancy [2]. As a consequence, there is a parallel increase of patients suffering from challenging and multifaceted syndromes such as heart failure (HF).


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.